About Rokshaw
Rokshaw is a Healthcare company based in Sunderland (United Kingdom) founded in 2012, and was acquired by Emmac in April 2019. Specialty medicines are manufactured and supplied across the UK. Rokshaw has raised $460.1 thousand across 1 funding round from investors including Emmac and North East Fund. Rokshaw offers products and services including Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Thistle Pharma Ltd.
Company details
Rokshaw was founded in 2012 in Sunderland, United Kingdom, as a manufacturer and supplier in the pharmaceutical sector. External dosage forms such as creams, ointments, soaps, ear drops, nasal drops, enema solutions, pessaries, paints, gels, pastes, and lotions are produced. Additional products include solutions, suspensions, lozenges, medicated lollipops, reefer packs, capsules, oral syringes, suppositories, and sachets. Services are extended to hospitals, wholesalers, pharmacies, and dispensing doctors throughout the UK.
- Headquarters Sunderland, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rokshaw.co.uk
- Social LinkedIn X Facebook
- Acquired by Emmac (Apr 2019)
- Legal Name Thistle Pharma Ltd
Products & Services of Rokshaw
Rokshaw offers a comprehensive portfolio of products and services, including Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports.
Manufactured unlicensed medicines for tariff-listed needs.
Custom formulations not on standard tariffs.
Sourced and supplied specific unlicensed products.
Imported unlicensed medicines for UK market.
Funding Insights of Rokshaw
Rokshaw has successfully raised a total of $460.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $460.1 thousand completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $460,100
- Total Rounds 1
- Last Round Seed — $460,100
- First Round $460,100
(Sep 2018)
- Investors Count 1
All 1 funding rounds of Rokshaw with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $460,100 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Rokshaw
Rokshaw has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Emmac and North East Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment finance is provided to small and medium-sized enterprises. | northeastfund.org | Newcastle upon Tyne, United Kingdom | ||
Medical cannabis products are produced and supplied by Emmac. | 2018 | emmac.com | London, United Kingdom |
Investor details for Rokshaw
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Rokshaw
3 dated milestones of Rokshaw across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Rokshaw is founded.
- Funding First funding round of $460K.
- Exit Acquired by Emmac.
Web traffic of Rokshaw
The website of Rokshaw (rokshaw.co.uk) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 56.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rokshaw
Complete news archive for Rokshaw
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rokshaw
Rokshaw was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Rokshaw is headquartered in Sunderland, United Kingdom. It is registered at Sunderland, England, United Kingdom.
Rokshaw is a funded company, having raised a total of $460.1K across 1 funding round to date. The company's 1st funding round was a Seed of $460.1K, raised on Sep 2018.
Rokshaw was founded in 2012 in Sunderland, United Kingdom, as a manufacturer and supplier in the pharmaceutical sector. External dosage forms such as creams, ointments, soaps, ear drops, nasal drops, enema solutions, pessaries, paints, gels, pastes, and lotions are produced. Additional products include solutions, suspensions, lozenges, medicated lollipops, reefer packs, capsules, oral syringes, suppositories, and sachets. Services are extended to hospitals, wholesalers, pharmacies, and dispensing doctors throughout the UK.
Rokshaw offers Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports.
Rokshaw has 2 investors. Key investors include Emmac, and North East Fund.
Rokshaw operates through Thistle Pharma Ltd.
Yes. Rokshaw was acquired by Emmac in April 2019.